Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

KYTH 74.56 +0.02 (0.03%)
price chart
Kythera Biopharmaceuticals Inc (KYTH) Files Form 4 Insider Selling : Camille D ...
Kythera Biopharmaceuticals Inc (KYTH): Camille D Samuels , director of Kythera Biopharmaceuticals Inc sold 250 shares on Aug 3, 2015.
Company Shares of Kythera Biopharmaceuticals, Inc. Rally 0.47%
Shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) appreciated by 0.47% during the past week but lost 0.55% on a 4-week basis.
Notable Session Mover: Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH)  Vanguard Tribune
Morgan & Morgan Announces the Investigation of KYTHERA Biopharmaceuticals, Inc ...
NEW YORK, June 19, 2015 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential claims against the board of directors of KYTHERA Biopharmaceuticals, Inc. ("KYTHERA" or the "Company") (NASDAQ: KYTH) concerning the proposed ...
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) is going to be acquired by ...  Inside Trade
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of KYTHERA ...  MarketWatch
Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion
Allergan Plc, the maker of wrinkle treatment Botox, agreed to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion to add treatments for double chins and male pattern baldness.
Why Kythera Biopharmaceuticals, Inc. Stock Soared Today  Motley Fool
Why Tripadvisor Inc (TRIP), Kythera Biopharmaceuticals Inc (KYTH) and Qihoo ...
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Short Interest Update
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) has witnessed a drop of 9.9% or 187,471 shares in its short figure. The short interest diminution took it from 1,897,697 on June 30,2015 to 1,710,226 on July 15,2015.
Shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Sees Large Inflow ...  Money Flow Index
Will Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) Surprise This Quarter?  Investor Newswire
Why Keith Leonard Unloaded 3500 Shares of Kythera Biopharmaceuticals Inc ...
In view of the deal Keith Leonard made he is in the bear's eye today. The President & CEO of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 74.40 -0.08 -0.11% and an insider, made a sale of 3,500 shares worth $175,151 USD. The average price was ...
Kythera Biopharmaceuticals Inc (KYTH) Insider Keith R Leonard Sells 3500 Shares.  News Watch International
Zacks Rating on Kythera Biopharmaceuticals, Inc.
As much as 4 analysts have advised buy on Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) with an average broker rating of 1.5.
Sell Kythera (KYTH) Stock, Another Biotech Ripoff
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) stock was halted Monday as an independent advisory committee reviewed its double-chin treatment, ATX-101.
Kythera Biopharmaceuticals Inc's (KYTH) Double-Chin Treatment Backed By ...  Bidness ETC
KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common Stock  GlobeNewswire (press release)
Why Allergan Plc Just Disclosed Huge New Kythera Biopharmaceuticals Inc Stake
Per Allergan Plc's filing, the filler now owns 6.7% of the Health Care-company, holding 1,760,048 shares. Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) is a newly disclosed equity position and the filing was required due to activity on June17, 2015.
Kythera Biopharmaceuticals Inc (KYTH) Files Form 4 Insider Selling : John W ...  Insider Trading Report
Leerink Downgrades Kythera, Says Allergan Deal Likely To Close At $75 Mark  Benzinga
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) Announces FDA Approval of ...
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) opened trading today as $45.24 and is trading in the range of 45.12-51.84 today.
Elisabeth Sandoval, an Insider in Kythera Biopharmaceuticals Inc (NASDAQ ...
KYTHERA Biopharmaceuticals to Release First Quarter 2015 Operating Results  GlobeNewswire (press release)